Assisted Hatching: Narrow Indications vs Blanket Use

Assisted hatching is a laboratory procedure in which the outer shell of the embryo — the zona pellucida — is thinned or partially opened before transfer. The theory: some embryos have zona pellucida issues (thickening, hardening from vitrification, poor hatching mechanics) that impair implantation. Helping them hatch might improve outcomes.

Assisted hatching can be done with acid, laser, or mechanical piercing. Modern programs use laser almost universally.

When Assisted Hatching Actually Helps

The Cochrane review of assisted hatching, updated in 2020, analyzed 39 randomized trials covering more than 7,000 patients. The overall finding: no meaningful benefit for the general IVF population. Live birth rates were similar with and without hatching.

Subgroup analyses did suggest possible benefit in specific situations:

Cryopreserved embryos

Vitrification can harden the zona pellucida in some embryos. Assisted hatching before frozen embryo transfer has shown modest benefit in some studies, particularly with older cryopreservation methods.

Older patients (typically ≥38)

Some data suggests women 38+ may benefit from hatching. Effect sizes are small and not consistent across all studies.

Recurrent implantation failure

Similar to endometrial scratch — subgroup with prior implantation failure sometimes shows benefit, though data quality varies.

Embryos with thick zona pellucida on morphology

If the embryologist identifies unusually thick zona pellucida during assessment, targeted hatching for those specific embryos is reasonable. This is a case-by-case decision rather than a blanket policy.

When Assisted Hatching Doesn't Help

Everyone else. The evidence for benefit in:

• First-cycle patients under 38 with normal-quality embryos
• Fresh transfers with no cryopreservation involved
• Patients with good prognosis and no prior implantation failure

...is essentially nil. Routine assisted hatching for these patients appears to be a cost without a benefit.

The Marketing vs Reality Gap

Assisted hatching is often bundled with premium IVF packages or offered as an upgrade at US$300–$1,000 per cycle. Some clinics market it as "improving implantation" without acknowledging the narrow evidence for benefit.

If your clinic offers it routinely to first-cycle patients under 38 with fresh transfer, the recommendation deserves questioning. Ask:

1. "In what subgroup does the evidence support this for my situation?"
2. "What effect size do you expect in a patient like me?"
3. "What's the twinning risk?"

Where It Reasonably Fits

Frozen embryo transfers

Reasonable to consider, especially for embryos frozen with older methods or for patients with prior failed FET.

Patients ≥38 with prior failed cycles

Reasonable to consider on a case-by-case basis.

Embryos with thick zona on morphology

Reasonable — this is targeted, evidence-based use.

Recurrent implantation failure workup

May be added to comprehensive workup and treatment plan.

What Modern Guidelines Say

• ASRM: does not recommend routine assisted hatching. Case-by-case based on clinical situation.
• ESHRE: notes limited evidence for benefit in general populations.
• HFEA: rated red-amber in traffic light system for most patient categories.

Colombia-Specific Notes

Colombian fertility centers vary in their approach. Some include laser assisted hatching as standard practice in cryopreserved embryo transfers with no additional charge; others offer it as an add-on. If it's included by default in the case of frozen transfer, that's a defensible clinic protocol. If it's being sold as a premium upgrade for your first fresh cycle, question the recommendation.